Stomach bug,” “cruise-ship virus,” “winter vomiting disease”—all are nicknames for norovirus, the top cause of vomiting, ...

Here are some of the major companies whose stocks moved on the week’s news.

Moderna's bird flu vaccine development, supported by a U.S. government grant, could be a game changer if the bird flu spreads ...

“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or ...

Shares of Moderna Inc. MRNA slid 2.13% to $42.25 Friday, on what proved to be an all-around rough trading session for the ...

Jim Cramer, host of Mad Money, recently discussed the current state of the market and also discussed both the leading and ...

Af Klint was formally trained at the Royal Academy of Fine Arts and initially focused on drawing, portraits, botanical ...

It wasn't just the pure-play AI stocks that benefited last year. Overall, it was a big year for big tech. In short, thanks to ...

A new weight loss biotech launched with $410 million and three assets from China. Roche's Chugai penned a deal to develop ...

A stomach illness outbreak at the University of Guelph is part of a trend that has experts noticing a rise in stomach bugs causing vomiting and diarrhea.

Moderna CSO, launches Kerna Labs with $6M seed funding to develop AI models for better mRNA drugs, partnering with Julia Peng ...